Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yosuke Yasuda

Showing results (51-60 of 93) with videos related to

Pageof 10
Sort By:
Urologic Oncology|January 5, 2025
Prognostic significance of body mass index in patients with metastatic renal cell carcinoma receiving first-line therapiesKeigo Sato, Kosuke Takemura, Ryosuke Oki, et al.
Japanese Journal of Clinical Oncology|April 29, 2026
Bayesian reanalysis of the NIAGARA trial using reconstructed individual patient data: perioperative durvalumab in cisplatin-eligible muscle-invasive bladder cancerKohei Hirose, Soichiro Yoshida, Wei Chen, et al.
International Journal of Clinical Oncology|July 23, 2017
Early response of C-reactive protein as a predictor of survival in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitorsYosuke Yasuda, Kazutaka Saito, Takeshi Yuasa, et al.
World Journal of Urology|January 13, 2022
Predicting GFR after radical nephrectomy: the importance of split renal functionNityam Rathi, Diego A Palacios, Emily Abramczyk, et al.
Clinical Genitourinary Cancer|April 12, 2022
Prognostic Significance of C-reactive Protein in Patients With Non-metastatic Papillary Renal Cell Carcinoma: Results from the INternational Marker Consortium for Renal Cancer (INMARC) CohortMasahiro Toide, Kazutaka Saito, Yosuke Yasuda, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|July 11, 2021
Nonuse of antimicrobial prophylaxis in clean surgeries for adrenal and renal tumors: Results of the risk-based strategy in 1362 consecutive patientsRiko Maruyama, Hiroshi Fukushima, Shohei Fukuda, et al.
Surgical Endoscopy|March 5, 2026
Human-in-the-loop validation of an artificial intelligence-driven real-time prostatic capsule recognition model for nerve-sparing robot-assisted radical prostatectomyWei Chen, Shohei Fukuda, Soichiro Yoshida, et al.
Medicina (Kaunas, Lithuania)|June 27, 2025
Preoperative Leg Muscle Quality Association Functional Recovery After Adult Spinal Deformity Surgery: A Propensity-Score-Matched StudyTomoyoshi Sakaguchi, Masato Tanaka, Shinya Arataki, et al.
Urologic Oncology|March 24, 2026
Diagnostic value of MRI-ultrasound fusion-targeted prostate biopsy for non-index lesions combined with the index lesion biopsyMasaki Kobayashi, Yoh Matsuoka, Koichiro Kimura, et al.
Urologic Oncology|February 19, 2025
Impact of IRAES on the outcomes of pembrolizumab therapy in patients with MUC: A comprehensive analysis of severity and the type and number of affected organsIchiro Yonese, Yosuke Yasuda, Kosuke Takemura, et al.
Pageof 10

Showing results (51-60 of 93) with videos related to

Sort By:
Pageof 10
Urologic Oncology|January 5, 2025
Prognostic significance of body mass index in patients with metastatic renal cell carcinoma receiving first-line therapiesKeigo Sato, Kosuke Takemura, Ryosuke Oki, et al.
Japanese Journal of Clinical Oncology|April 29, 2026
Bayesian reanalysis of the NIAGARA trial using reconstructed individual patient data: perioperative durvalumab in cisplatin-eligible muscle-invasive bladder cancerKohei Hirose, Soichiro Yoshida, Wei Chen, et al.
International Journal of Clinical Oncology|July 23, 2017
Early response of C-reactive protein as a predictor of survival in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitorsYosuke Yasuda, Kazutaka Saito, Takeshi Yuasa, et al.
World Journal of Urology|January 13, 2022
Predicting GFR after radical nephrectomy: the importance of split renal functionNityam Rathi, Diego A Palacios, Emily Abramczyk, et al.
Clinical Genitourinary Cancer|April 12, 2022
Prognostic Significance of C-reactive Protein in Patients With Non-metastatic Papillary Renal Cell Carcinoma: Results from the INternational Marker Consortium for Renal Cancer (INMARC) CohortMasahiro Toide, Kazutaka Saito, Yosuke Yasuda, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|July 11, 2021
Nonuse of antimicrobial prophylaxis in clean surgeries for adrenal and renal tumors: Results of the risk-based strategy in 1362 consecutive patientsRiko Maruyama, Hiroshi Fukushima, Shohei Fukuda, et al.
Surgical Endoscopy|March 5, 2026
Human-in-the-loop validation of an artificial intelligence-driven real-time prostatic capsule recognition model for nerve-sparing robot-assisted radical prostatectomyWei Chen, Shohei Fukuda, Soichiro Yoshida, et al.
Medicina (Kaunas, Lithuania)|June 27, 2025
Preoperative Leg Muscle Quality Association Functional Recovery After Adult Spinal Deformity Surgery: A Propensity-Score-Matched StudyTomoyoshi Sakaguchi, Masato Tanaka, Shinya Arataki, et al.
Urologic Oncology|March 24, 2026
Diagnostic value of MRI-ultrasound fusion-targeted prostate biopsy for non-index lesions combined with the index lesion biopsyMasaki Kobayashi, Yoh Matsuoka, Koichiro Kimura, et al.
Urologic Oncology|February 19, 2025
Impact of IRAES on the outcomes of pembrolizumab therapy in patients with MUC: A comprehensive analysis of severity and the type and number of affected organsIchiro Yonese, Yosuke Yasuda, Kosuke Takemura, et al.
Pageof 10